BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 8780425)

  • 61. Assessment of comorbid psychiatric illness and substance disorders.
    Kofoed L
    New Dir Ment Health Serv; 1991; (50):43-55. PubMed ID: 1886549
    [No Abstract]   [Full Text] [Related]  

  • 62. Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders.
    Miele GM; Carpenter KM; Smith Cockerham M; Trautman KD; Blaine J; Hasin DS
    Drug Alcohol Depend; 2000 Apr; 59(1):63-75. PubMed ID: 10706976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Psychotic patients with unclear diagnoses. A descriptive analysis.
    Fennig S; Bromet EJ; Craig T; Jandorf L; Schwartz JE
    J Nerv Ment Dis; 1995 Apr; 183(4):207-13. PubMed ID: 7714509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coexisting psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population.
    Adamson SJ; Todd FC; Sellman JD; Huriwai T; Porter J
    Aust N Z J Psychiatry; 2006 Feb; 40(2):164-70. PubMed ID: 16476135
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Young female alcoholics with and without eating disorders: a comparative study in Japan.
    Suzuki K; Higuchi S; Yamada K; Mizutani Y; Kono H
    Am J Psychiatry; 1993 Jul; 150(7):1053-8. PubMed ID: 8317575
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gender differences in substance use disorders.
    Brady KT; Grice DE; Dustan L; Randall C
    Am J Psychiatry; 1993 Nov; 150(11):1707-11. PubMed ID: 8214180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical diagnosis of substance use disorders in private psychiatric populations.
    Miller NS; Belkin BM; Gibbons R
    J Subst Abuse Treat; 1994; 11(4):387-92. PubMed ID: 7966510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of facility and research diagnoses in first-admission psychotic patients.
    Fennig S; Craig TJ; Tanenberg-Karant M; Bromet EJ
    Am J Psychiatry; 1994 Oct; 151(10):1423-9. PubMed ID: 8092336
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence of dual diagnoses of mental and substance abuse disorders in general hospitals.
    Kiesler CA; Simpkins CG; Morton TL
    Hosp Community Psychiatry; 1991 Apr; 42(4):400-3. PubMed ID: 1904835
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers.
    Cecero JJ; Ball SA; Tennen H; Kranzler HR; Rounsaville BJ
    J Nerv Ment Dis; 1999 Aug; 187(8):478-86. PubMed ID: 10463065
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Personality disorders in substance abusers: relation to substance use.
    Rounsaville BJ; Kranzler HR; Ball S; Tennen H; Poling J; Triffleman E
    J Nerv Ment Dis; 1998 Feb; 186(2):87-95. PubMed ID: 9484308
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comorbidity of fibromyalgia and psychiatric disorders.
    Arnold LM; Hudson JI; Keck PE; Auchenbach MB; Javaras KN; Hess EV
    J Clin Psychiatry; 2006 Aug; 67(8):1219-25. PubMed ID: 16965199
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome.
    Brown RA; Monti PM; Myers MG; Martin RA; Rivinus T; Dubreuil ME; Rohsenow DJ
    Am J Psychiatry; 1998 Feb; 155(2):220-5. PubMed ID: 9464201
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Utility of the Time-Line Follow-Back to assess substance use among homeless adults.
    Sacks JA; Drake RE; Williams VF; Banks SM; Herrell JM
    J Nerv Ment Dis; 2003 Mar; 191(3):145-53. PubMed ID: 12637840
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Psychiatric disorders in relatives of probands with opiate addiction.
    Rounsaville BJ; Kosten TR; Weissman MM; Prusoff B; Pauls D; Anton SF; Merikangas K
    Arch Gen Psychiatry; 1991 Jan; 48(1):33-42. PubMed ID: 1984760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reliability of diagnoses made by psychiatric residents in a general emergency department.
    Warner MD; Peabody CA
    Psychiatr Serv; 1995 Dec; 46(12):1284-6. PubMed ID: 8590116
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of Composite International Diagnostic Interview and clinical DSM-III-R criteria checklist diagnoses.
    Janca A; Robins LN; Bucholz KK; Early TS; Shayka JJ
    Acta Psychiatr Scand; 1992 Jun; 85(6):440-3. PubMed ID: 1642126
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Initial results, reliability, and validity of a mental health survey of Mount Pinatubo disaster victims.
    Howard WT; Loberiza FR; Pfohl BM; Thorne PS; Magpantay RL; Woolson RF
    J Nerv Ment Dis; 1999 Nov; 187(11):661-72. PubMed ID: 10579594
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Test-retest reliability of the alcohol and drug use disorder sections of the schedules for clinical assessment in neuropsychiatry (SCAN).
    Easton C; Meza E; Mager D; Ulüg B; Kilic C; Göğüş A; Babor TF
    Drug Alcohol Depend; 1997 Sep; 47(3):187-94. PubMed ID: 9306044
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cross system agreement for substance use disorders: DSM-III-R, DSM-IV and ICD-10.
    Rounsaville BJ; Bryant K; Babor T; Kranzler H; Kadden R
    Addiction; 1993 Mar; 88(3):337-48. PubMed ID: 8461851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.